Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver - Wikidata - wikimedia - TriplyDB

Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver

Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver

http://www.wikidata.org/entity/Q34382587

about

Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression Vascular changes in hepatocellular carcinoma.Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features.Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published work.Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.Transforming growth factor beta1 gene variation Leu10Pro affects secretion and function in hepatic cells.Morphometric evaluation of vascularization of hepatic focal nodular hyperplasia.Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis.Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas.Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.Oncogenic Signaling Induced by HCV Infection Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry

P2860

Q26853543-D363153A-DE6A-4FAA-A027-E40295FE39B4 Q33289829-FF31CB6E-C78B-47B4-82BE-636875E839BB Q33843943-FD9C81E5-BB68-4490-8428-FAA3FA110B33 Q35089199-CA2C612A-484C-4DC0-971E-2534ED2F0A8C Q37165456-73E53FAE-2071-47EF-8320-9780E654AB31 Q37412221-BBF19C87-66E7-4B43-AF8D-0D24C0618DB0 Q37820212-ACC6A9CC-20C8-463A-B694-F920BE1D0397 Q38078237-DF70E5CD-EAFA-4D6B-B1C7-B894721C7300 Q38320933-4ED0F631-2C8D-4EAC-B5CF-4012A465DA00 Q38631740-900E8DC1-DDA3-43E2-8749-C3D52230D63C Q38737103-165CB8A6-6583-4A2E-A43F-2364466CE608 Q39344643-E133900A-5F8A-413A-A156-4883C84F48E6 Q44130433-5EE908CE-2FE2-457D-A706-0D075F73A975 Q45928109-3678BBA8-AA5C-45EB-9DAF-48655CD168F4 Q49229192-9DA6CD6A-81DF-4975-AEB6-2AF3205CF8F2 Q55467287-45C8BA7D-E5A8-412E-B0EE-55DB852E0F12 Q57050806-535F2161-095F-4DEB-A42D-4A0DF808AF86 Q58804278-8EEFCA15-DC1C-4A2A-A519-A8CF0C2BF9FE Q58804683-4CD8617B-8158-42AD-8A33-1BB058AA8C4B

P2860

Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver

http://www.wikidata.org/entity/Q34382587

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Clinicopathological and progno ...... ts adjacent non-tumorous liver

@ast

Clinicopathological and progno ...... ts adjacent non-tumorous liver

@en

Clinicopathological and prognostic implications of endoglin

@nl

type

label

Clinicopathological and progno ...... ts adjacent non-tumorous liver

@ast

Clinicopathological and progno ...... ts adjacent non-tumorous liver

@en

Clinicopathological and prognostic implications of endoglin

@nl

prefLabel

Clinicopathological and progno ...... ts adjacent non-tumorous liver

@ast

Clinicopathological and progno ...... ts adjacent non-tumorous liver

@en

Clinicopathological and prognostic implications of endoglin

@nl

P1433

Q34382587-7F8E0F67-837A-4B35-953A-C172CDA63B16

P1476

Q34382587-40B89D15-E4C2-4AE4-8F88-E36346339FF7

P2093

Q34382587-0BCC2E1B-15F3-41C6-9DE0-C4AF7AE9FECA

Q34382587-A68C05EC-0625-490B-859C-3F9B3FC10FA8

Q34382587-AF5E4EC5-9757-464A-8093-9838C837F834

Q34382587-BAF99333-88A8-4317-893B-9AE5D97F3557

Q34382587-C68C45D0-8BEF-4E07-932C-5C7F9B35966E

P2860

Q34382587-0405B1BA-37C8-4EFE-A892-515600B0EFE9

Q34382587-12F8B7E7-67A6-45A5-A298-0E19610E2BC1

Q34382587-32496412-5CAA-4775-A99F-67F13012C91D

Q34382587-37F435B3-1A26-4D01-99D1-B6A0A984EF12

Q34382587-6B75EFFE-E6AA-4396-B919-77D851F99095

Q34382587-7E9FC661-58AA-406C-B188-2A85F82EED2E

Q34382587-7F7702AC-0EAF-4A25-B0BE-7390021621D7

Q34382587-851E7794-499C-42FA-94F7-A577B0C66686

Q34382587-96E34474-04AA-4542-86CE-C9246D164E92

Q34382587-AA000DF0-75E6-4FC2-8999-74BEA64ED587

P304

Q34382587-355ED430-79C0-4FD2-B453-BE26D16972C9

P31

Q34382587-68245CCE-F5D5-4FD3-AE6F-7D09848C84A4

P356

Q34382587-BFFD9D66-14FE-4D5D-9C1E-A3AC3EBFBAE7

P407

Q34382587-D29FFF8B-E030-487D-B21B-466F620C4169

P433

Q34382587-C825B174-F5B9-48E2-BA3C-17D13D649F98

P478

Q34382587-E3371D08-F8AA-48D6-8D94-718353E0773B

P577

Q34382587-7FFEAE7B-EB52-4190-9DD2-44E87E203BF4

P5875

Q34382587-C921CFAE-1053-4794-841C-CF2779422860

P698

Q34382587-4E5B7027-8251-493C-BD94-97B26C3F9A3E

P932

Q34382587-50A3A170-BD08-4879-8307-37DC110B41FC

P356

P1433

World Journal of Gastroenterology

P1476

Clinicopathological and progno ...... ts adjacent non-tumorous liver

@en

P2093

Chris-K Sun

http://www.w3.org/2001/XMLSchema#string

Joanna-W Ho

http://www.w3.org/2001/XMLSchema#string

Ronnie-T Poon

http://www.w3.org/2001/XMLSchema#string

Sheung-Tat Fan

http://www.w3.org/2001/XMLSchema#string

Wei-Cheng Xue

http://www.w3.org/2001/XMLSchema#string

P2860

What is the evidence that tumors are angiogenesis dependent?

Clinical significance of determination of surrogate markers of angiogenesis in breast cancer.

NIR reflection measurements of hemoglobin and cytochrome aa3 in healthy tissue and tumors. Correlations to oxygen consumption: preclinical and clinical data.

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Endothelial proliferation in tumours and normal tissues: continuous labelling studies.

Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1.

Hypoxia in neoplastic tissue.

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.

P304

176-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I2.176

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8098190

http://www.w3.org/2001/XMLSchema#string

P698

15633211

http://www.w3.org/2001/XMLSchema#string

P932

4205397

http://www.w3.org/2001/XMLSchema#string